These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 35366993)
1. Preclinical model of multiple sclerosis: Focal, chemical or viral demyelination. Tsirka SE; Nissen JC Methods Cell Biol; 2022; 168():87-102. PubMed ID: 35366993 [TBL] [Abstract][Full Text] [Related]
2. Mobilization of progenitors in the subventricular zone to undergo oligodendrogenesis in the Theiler's virus model of multiple sclerosis: implications for remyelination at lesions sites. Mecha M; Feliú A; Carrillo-Salinas FJ; Mestre L; Guaza C Exp Neurol; 2013 Dec; 250():348-52. PubMed ID: 24148569 [TBL] [Abstract][Full Text] [Related]
3. Effectors of demyelination and remyelination in the CNS: implications for multiple sclerosis. Rodriguez M Brain Pathol; 2007 Apr; 17(2):219-29. PubMed ID: 17388953 [TBL] [Abstract][Full Text] [Related]
4. The role of oligodendrocytes and oligodendrocyte progenitors in CNS remyelination. Keirstead HS; Blakemore WF Adv Exp Med Biol; 1999; 468():183-97. PubMed ID: 10635029 [TBL] [Abstract][Full Text] [Related]
5. rHIgM22 enhances remyelination in the brain of the cuprizone mouse model of demyelination. Mullin AP; Cui C; Wang Y; Wang J; Troy E; Caggiano AO; Parry TJ; Colburn RW; Pavlopoulos E Neurobiol Dis; 2017 Sep; 105():142-155. PubMed ID: 28576706 [TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo models of multiple sclerosis. van der Star BJ; Vogel DY; Kipp M; Puentes F; Baker D; Amor S CNS Neurol Disord Drug Targets; 2012 Aug; 11(5):570-88. PubMed ID: 22583443 [TBL] [Abstract][Full Text] [Related]
7. Central nervous system demyelination and remyelination in multiple sclerosis and viral models of disease. Rodriguez M J Neuroimmunol; 1992 Oct; 40(2-3):255-63. PubMed ID: 1430155 [TBL] [Abstract][Full Text] [Related]
8. Chronic toxic demyelination in the central nervous system leads to axonal damage despite remyelination. Lindner M; Fokuhl J; Linsmeier F; Trebst C; Stangel M Neurosci Lett; 2009 Apr; 453(2):120-5. PubMed ID: 19356606 [TBL] [Abstract][Full Text] [Related]
9. Inactivation of Protein Tyrosine Phosphatase Receptor Type Z by Pleiotrophin Promotes Remyelination through Activation of Differentiation of Oligodendrocyte Precursor Cells. Kuboyama K; Fujikawa A; Suzuki R; Noda M J Neurosci; 2015 Sep; 35(35):12162-71. PubMed ID: 26338327 [TBL] [Abstract][Full Text] [Related]
10. Galectin-4, a Negative Regulator of Oligodendrocyte Differentiation, Is Persistently Present in Axons and Microglia/Macrophages in Multiple Sclerosis Lesions. de Jong CGHM; Stancic M; Pinxterhuis TH; van Horssen J; van Dam AM; Gabius HJ; Baron W J Neuropathol Exp Neurol; 2018 Nov; 77(11):1024-1038. PubMed ID: 30252090 [TBL] [Abstract][Full Text] [Related]
11. The adult oligodendrocyte can participate in remyelination. Duncan ID; Radcliff AB; Heidari M; Kidd G; August BK; Wierenga LA Proc Natl Acad Sci U S A; 2018 Dec; 115(50):E11807-E11816. PubMed ID: 30487224 [TBL] [Abstract][Full Text] [Related]
12. Loss of Tuberous Sclerosis Complex1 in Adult Oligodendrocyte Progenitor Cells Enhances Axon Remyelination and Increases Myelin Thickness after a Focal Demyelination. McLane LE; Bourne JN; Evangelou AV; Khandker L; Macklin WB; Wood TL J Neurosci; 2017 Aug; 37(31):7534-7546. PubMed ID: 28694334 [TBL] [Abstract][Full Text] [Related]
13. Selective ultrastructural vulnerability in the cuprizone-induced experimental demyelination. Acs P; Komoly S Ideggyogy Sz; 2012 Jul; 65(7-8):266-70. PubMed ID: 23074847 [TBL] [Abstract][Full Text] [Related]
14. Acutely damaged axons are remyelinated in multiple sclerosis and experimental models of demyelination. Schultz V; van der Meer F; Wrzos C; Scheidt U; Bahn E; Stadelmann C; Brück W; Junker A Glia; 2017 Aug; 65(8):1350-1360. PubMed ID: 28560740 [TBL] [Abstract][Full Text] [Related]
15. EBI2 is expressed in glial cells in multiple sclerosis lesions, and its knock-out modulates remyelination in the cuprizone model. Klejbor I; Shimshek DR; Klimaszewska-Łata J; Velasco-Estevez M; Moryś J; Karaszewski B; Szutowicz A; Rutkowska A Eur J Neurosci; 2021 Aug; 54(3):5173-5188. PubMed ID: 34145920 [TBL] [Abstract][Full Text] [Related]
17. The Cannabinoid CB1/CB2 Agonist WIN55212.2 Promotes Oligodendrocyte Differentiation In Vitro and Neuroprotection During the Cuprizone-Induced Central Nervous System Demyelination. Tomas-Roig J; Wirths O; Salinas-Riester G; Havemann-Reinecke U CNS Neurosci Ther; 2016 May; 22(5):387-95. PubMed ID: 26842941 [TBL] [Abstract][Full Text] [Related]
18. Thymosin beta4 promotes oligodendrogenesis in the demyelinating central nervous system. Zhang J; Zhang ZG; Li Y; Lu M; Zhang Y; Elias SB; Chopp M Neurobiol Dis; 2016 Apr; 88():85-95. PubMed ID: 26805386 [TBL] [Abstract][Full Text] [Related]
19. Mitochondrial DNA Double-Strand Breaks in Oligodendrocytes Cause Demyelination, Axonal Injury, and CNS Inflammation. Madsen PM; Pinto M; Patel S; McCarthy S; Gao H; Taherian M; Karmally S; Pereira CV; Dvoriantchikova G; Ivanov D; Tanaka KF; Moraes CT; Brambilla R J Neurosci; 2017 Oct; 37(42):10185-10199. PubMed ID: 28931570 [TBL] [Abstract][Full Text] [Related]
20. Immune promotion of central nervous system remyelination. Rodriguez M; Miller DJ Prog Brain Res; 1994; 103():343-55. PubMed ID: 7886217 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]